Machine Learning

Europe's largest cinema chain partners with Pixelworks, bringing motion-enhanced films to its premium screens to boost clarity and preserve artistic intent.

At a key industry summit, Sutro Biopharma showcases its next-gen ADC platform, designed to overcome treatment resistance with "supercharged" dual-payload drugs.

As Lyell presents at three major investor conferences, the biotech's pipeline, financial health, and future in cancer therapy are under scrutiny.

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

An international initiative uniting a Japanese firm, the UN, and Aikido masters empowers Los Angeles women with non-violent self-defense techniques.

AI firm DreamzTech Solutions gains major recognition, validating its AI-first strategy and signaling a new wave of Indian tech leaders on the global stage.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

iRegene Therapeutics hits dual milestones, advancing AI-derived cell therapies for Parkinson's in the US and Multiple System Atrophy in China.

Light Source Communications is building a massive underground dark fiber network to connect St. Louis and Tulsa, powering the AI revolution in the heartland.

With a soaring stock, $300M in new funding, and strong clinical data, Monte Rosa is set to showcase its novel disease-fighting drug platform.

New 12- and 24-month data for Benitec Biopharma's BB-301 gene therapy offers renewed hope for patients with a rare, debilitating muscular dystrophy.

Anavex Life Sciences adds AMEOS Group CEO Dr. Axel Paeger to its board, a strategic move signaling a push into European markets for its CNS therapies.

C4 Therapeutics begins a crucial study for its oral protein degrader, cemsidomide, offering new hope for heavily treated multiple myeloma patients.

With a key drug in trials and a pipeline nearing the clinic, Foghorn Therapeutics brings in a seasoned financial leader to navigate its path to market.

El Salvador is overhauling its customs with Smiths Detection's high-speed X-ray scanners, aiming to curb illicit trade and accelerate commerce.

A new partnership aims to turn a polytechnic campus into a living lab for sustainability, using IIoT to slash energy use and train a new generation of innovators.

AxyomCore unveils a powerful 4G/5G network extender at MWC, claiming superior coverage and capacity that could disrupt the enterprise connectivity market.

Beyond affordability, India is positioning itself as a trusted global health hub by blending modern medicine with ancient wisdom to fuel its economy.

A landmark partnership aims to slash BCI development costs from $100M to $5M, accelerating therapies and the quest for a human brain AI model.